Core Insights - Veeva Systems has launched Veeva eSource, a new application aimed at reducing manual processes in clinical trials and enhancing data quality through direct data capture and integration with EHR and EDC systems [1][3]. Group 1: Product Features - Veeva eSource eliminates paper at clinical trial sites by providing a direct data capture application, streamlining data flow through EDC integration and EHR to EDC transfer [1][6]. - The application automates the flow of patient data from eSource to Veeva EDC, reducing latency and minimizing errors, while also allowing sites to create forms that align with study protocols [6]. - By using source data instead of transcribed data, Veeva eSource eliminates the need for source data verification (SDV), allowing sponsor staff to allocate their time more effectively [6]. Group 2: Industry Impact - The introduction of Veeva eSource is seen as a significant advancement towards simplifying and standardizing clinical trials, ultimately improving efficiency and experiences for sponsors, sites, and patients [3]. - The application is part of the Veeva SiteVault platform and is expected to be available for early adopters in the second half of 2026, indicating a strategic move to enhance clinical trial processes [3]. Group 3: Company Overview - Veeva Systems provides cloud-based solutions for the life sciences industry, serving over 1,500 customers, including major biopharmaceutical companies and emerging biotechs [4]. - As a Public Benefit Corporation, Veeva is dedicated to balancing the interests of various stakeholders, including customers, employees, and shareholders [4].